- cafead   Jul 30, 2019 at 11:42: AM
via In anticipation of a long-awaited — and somewhat delayed — date with the FDA on its topical dermatology drugs, Foamix has returned to its biggest shareholders to stack up resources for the commercial stretch ahead.
article source
article source